• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉搭桥术后闭塞性冠状动脉疾病管理的进展

Advances in the Post-coronary Artery Bypass Graft Management of Occlusive Coronary Artery Disease.

作者信息

Rahman Mohammed Shamim, de Winter Ruben, Nap Alex, Knaapen Paul

机构信息

Department of Cardiology, Birmingham City Hospital, SWBH NHS Trust Birmingham, UK.

Department of Cardiology, Amsterdam Medical Centre, VU Medical Centre Amsterdam, the Netherlands.

出版信息

Interv Cardiol. 2021 Dec 24;16:e33. doi: 10.15420/icr.2021.12. eCollection 2021 Apr.

DOI:10.15420/icr.2021.12
PMID:35106069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8785096/
Abstract

Revascularisation of chronic total occlusion (CTO) represents one of the most challenging aspects of percutaneous coronary intervention, but advances in equipment and an understanding of CTO revascularisation techniques have resulted in considerable improvements in success rates. In patients with prior coronary artery bypass grafting (CABG) surgery, additional challenges are encountered. This article specifically explores these challenges, as well as antegrade methods of CTO crossing. Techniques, equipment that can be used and reference texts are highlighted with the aim of providing potential CTO operators adequate information to tackle additional complexities likely to be encountered in this cohort of patients. This review forms part of a wider series where additional aspects of patients with prior CABG should be factored into decisions and methods of revascularisation.

摘要

慢性完全闭塞病变(CTO)的血管重建是经皮冠状动脉介入治疗中最具挑战性的方面之一,但设备的进步以及对CTO血管重建技术的理解已使成功率有了显著提高。对于既往接受过冠状动脉旁路移植术(CABG)的患者,会遇到更多挑战。本文专门探讨这些挑战以及CTO正向通过的方法。文中重点介绍了相关技术、可使用的设备和参考文献,旨在为潜在的CTO手术操作者提供足够的信息,以应对该类患者群体可能遇到的额外复杂性。本综述是一个更广泛系列的一部分,在血管重建的决策和方法中应考虑既往接受CABG患者的其他方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/8785096/8e749b029041/icr-16-e33-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/8785096/8e749b029041/icr-16-e33-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/8785096/8e749b029041/icr-16-e33-g001.jpg

相似文献

1
Advances in the Post-coronary Artery Bypass Graft Management of Occlusive Coronary Artery Disease.冠状动脉搭桥术后闭塞性冠状动脉疾病管理的进展
Interv Cardiol. 2021 Dec 24;16:e33. doi: 10.15420/icr.2021.12. eCollection 2021 Apr.
2
The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry.Hybrid 策略在慢性完全闭塞经皮冠状动脉介入治疗中的应用:来自 PROGRESS CTO 注册研究的更新。
JACC Cardiovasc Interv. 2018 Jul 23;11(14):1325-1335. doi: 10.1016/j.jcin.2018.02.036. Epub 2018 Apr 26.
3
Impact of Crossing Strategy on Intermediate-term Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention.慢性完全闭塞性经皮冠状动脉介入治疗后交叉策略对中期结局的影响
Can J Cardiol. 2016 Oct;32(10):1239.e1-1239.e7. doi: 10.1016/j.cjca.2016.01.020. Epub 2016 Jan 23.
4
Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry.美国当代多中心注册研究中慢性完全闭塞性经皮冠状动脉介入治疗混合方法的应用及结果
Int J Cardiol. 2015 Nov 1;198:222-8. doi: 10.1016/j.ijcard.2015.06.093. Epub 2015 Jun 27.
5
In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Prior Coronary Artery Bypass Graft Surgery.经皮冠状动脉介入治疗慢性完全闭塞病变患者中既往冠状动脉旁路移植术的住院结局。
Circ Cardiovasc Interv. 2019 Mar;12(3):e007338. doi: 10.1161/CIRCINTERVENTIONS.118.007338.
6
Recanalization of Chronic Total Occlusions in Patients With Previous Coronary Bypass Surgery and Consideration of Retrograde Access via Saphenous Vein Grafts.既往接受冠状动脉搭桥手术患者慢性完全闭塞病变的再通及经大隐静脉桥逆行入路的考量
Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.115.003515.
7
Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGium, and UnitEd Kingdom (RECHARGE).在慢性完全闭塞经皮冠状动脉介入治疗患者中,先前冠状动脉旁路移植术的影响:法国、荷兰、比利时和英国的 Crossboss 和杂交手术登记处(RECHARGE)的手术和临床结果。
Catheter Cardiovasc Interv. 2021 Jan 1;97(1):E51-E60. doi: 10.1002/ccd.28954. Epub 2020 May 5.
8
Initial success rate of percutaneous coronary intervention for chronic total occlusion in a native coronary artery is decreased in patients who underwent previous coronary artery bypass graft surgery.经皮冠状动脉介入治疗在既往接受冠状动脉旁路移植术的患者中,用于治疗原位冠状动脉慢性完全闭塞的初始成功率降低。
JACC Cardiovasc Interv. 2014 Jan;7(1):39-46. doi: 10.1016/j.jcin.2013.08.012.
9
Stingray-ADR technique creating a channel between double CTO lesions in a previous CABG patient.在一名曾接受冠状动脉旁路移植术(CABG)的患者中,使用黄貂鱼-药物洗脱球囊血管成形术(Stingray-ADR)技术在双冠状动脉慢性完全闭塞(CTO)病变之间创建通道。
BMC Cardiovasc Disord. 2025 May 6;25(1):351. doi: 10.1186/s12872-025-04799-1.
10
Percutaneous coronary intervention of chronic total occlusion in patients with prior coronary artery bypass graft: the current situation.既往有冠状动脉旁路移植术患者慢性完全闭塞病变的经皮冠状动脉介入治疗:现状
J Invasive Cardiol. 2025 Jul;37(7). doi: 10.25270/jic/24.00301.

本文引用的文献

1
Percutaneous Coronary Intervention for Chronic Total Occlusion.经皮冠状动脉介入治疗慢性完全闭塞病变
US Cardiol. 2020 Sep 29;14:e11. doi: 10.15420/usc.2020.10. eCollection 2020.
2
Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial.药物洗脱支架与金属裸支架置入治疗隐静脉桥的长期结果:随机对照试验。
J Am Heart Assoc. 2020 Oct 20;9(20):e017434. doi: 10.1161/JAHA.120.017434. Epub 2020 Oct 9.
3
One-year outcomes of percutaneous coronary intervention in native coronary arteries versus saphenous vein grafts in patients with prior coronary artery bypass graft surgery.
经皮冠状动脉介入治疗在既往冠状动脉旁路移植术患者中的原生冠状动脉与隐静脉桥中的 1 年结果。
Cardiol J. 2022;29(3):396-404. doi: 10.5603/CJ.a2020.0131. Epub 2020 Oct 1.
4
Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.替格瑞洛联合标准阿司匹林对冠状动脉旁路移植术患者隐静脉桥通畅率的影响(POPular CABG):一项随机、双盲、安慰剂对照试验。
Circulation. 2020 Nov 10;142(19):1799-1807. doi: 10.1161/CIRCULATIONAHA.120.050749. Epub 2020 Aug 31.
5
[Comparison of graft vessel versus native vessel strategies for late saphenous vein graft disease after coronary artery bypass grafting].冠状动脉旁路移植术后大隐静脉移植血管晚期病变的移植血管与自体血管策略比较
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 May 24;48(5):367-372. doi: 10.3760/cma.j.cn112148-20190827-00523.
6
Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGium, and UnitEd Kingdom (RECHARGE).在慢性完全闭塞经皮冠状动脉介入治疗患者中,先前冠状动脉旁路移植术的影响:法国、荷兰、比利时和英国的 Crossboss 和杂交手术登记处(RECHARGE)的手术和临床结果。
Catheter Cardiovasc Interv. 2021 Jan 1;97(1):E51-E60. doi: 10.1002/ccd.28954. Epub 2020 May 5.
7
What is the cause of hypotension? A rare complication of percutaneous coronary intervention of a chronic total occlusion: a case report.低血压的病因是什么?慢性完全闭塞性冠状动脉介入治疗的一种罕见并发症:病例报告。
Eur Heart J Case Rep. 2019 Oct 22;3(4):1-5. doi: 10.1093/ehjcr/ytz184. eCollection 2019 Dec.
8
Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial.单纯支架置入术与辅助球囊血管成形术治疗隐静脉桥血管经皮冠状动脉介入治疗:来自 DIVA 试验的见解。
Circ Cardiovasc Interv. 2020 Feb;13(2):e008494. doi: 10.1161/CIRCINTERVENTIONS.119.008494. Epub 2020 Feb 5.
9
Outcomes Following Percutaneous Coronary Intervention in Saphenous Vein Grafts With and Without Embolic Protection Devices.经皮冠状动脉介入治疗中应用和不应用血栓保护装置的隐静脉桥的结果。
JACC Cardiovasc Interv. 2019 Nov 25;12(22):2286-2295. doi: 10.1016/j.jcin.2019.08.037.
10
Plaque Sealing With Drug-Eluting Stents Versus Medical Therapy for Treating Intermediate Non-Obstructive Saphenous Vein Graft Lesions: A Pooled Analysis of the VELETI and VELETI II Trials.药物洗脱支架斑块封堵术与药物治疗用于治疗中等程度非阻塞性大隐静脉移植血管病变的比较:VELETI和VELETI II试验的汇总分析
J Invasive Cardiol. 2019 Nov;31(11):E308-E315.